Thyroid Diseases

The grounding supports autoimmune mechanisms as a cause for some thyroid diseases, including Hashimoto's thyroiditis and Graves' disease. It also supports heritable single-gene defects in thyroid hormone transport, metabolism, and action as causes of rare thyroid hormone sensitivity disorders.

Thyroid disease can involve abnormal thyroid hormone production, transport, metabolism, or tissue response to hormone action. The literature links thyroid dysfunction to altered glucose and lipid metabolism, insulin resistance, endothelial dysfunction, and changes in peripheral tissues such as liver, adipose tissue, skeletal muscle, pancreas, and the gastrointestinal tract. Autoimmune thyroid disease is also associated with immune activation, intestinal barrier dysfunction, increased intestinal permeability, and microbiota-related effects.

Maternal hypothyroidism and hyperthyroidism are risk factors for preterm birth. Diabetes mellitus is associated with a higher prevalence of thyroid disorders, and thyroid dysfunction is also linked with metabolic syndrome and cardiovascular risk. The literature also notes co-occurrence with celiac disease and non-celiac wheat sensitivity in autoimmune thyroid disease.

Management depends on the specific thyroid disorder, but the supplied grounding does not provide a general treatment standard for all thyroid diseases. For rare genetic disorders of thyroid hormone transport, metabolism, and action, the guidelines emphasize diagnosis using clinical features and molecular genetic testing, followed by condition-specific management and therapy. The grounding does not support a broader drug-class or modality summary for all thyroid diseases.